Humedix Co., Ltd. (KOSDAQ:200670)

Market Cap	413.84B
Revenue (ttm)	110.99B
Net Income (ttm)	9.06B
Shares Out	10.32M
EPS (ttm)	963.99
PE Ratio	41.60
Forward PE	9.01
Dividend	660.00 (1.63%)
Ex-Dividend Date	Nov 24, 2025

Volume	80,719
Average Volume	74,200
Open	40,500
Previous Close	40,400
Day's Range	39,400 - 40,500
52-Week Range	32,850 - 77,200
Beta	0.39
RSI	41.99
Earnings Date	Feb 11, 2026

About Humedix

Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetic, and health functional food products. It is also involved in manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 248
• Stock Exchange: KOSDAQ
• Ticker Symbol: 200670

Financial Performance

In 2021, Humedix's revenue was 110.99 billion, an increase of 12.70% compared to the previous year's 98.48 billion. Earnings were 9.06 billion, a decrease of -39.91%.